These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38944709)

  • 1. Comparative Study of Treatment Outcome with Tenofovir Alafenamide and Entecavir in Patients with HBV Related Acute on Chronic Liver Failure.
    Somon MAU; Shwapnil MAM; Debnath CR; Noor-E-Alam SM; Tarafdar AJ; Ahmad MF; Ashrafujjaman M; Jhily KRA; Ashiq MS; Hasan MZ
    Mymensingh Med J; 2024 Jul; 33(3):696-705. PubMed ID: 38944709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tenofovir alafenamide and entecavir for hepatitis B virus
    Peng W; Gu H; Jiang C; Liu J; Zhang J; Fu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):194-201. PubMed ID: 35545409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C.
    Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Wu XN; Yang JH
    J Clin Gastroenterol; 2019 Apr; 53(4):e171-e177. PubMed ID: 29659382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y
    Clin Transl Gastroenterol; 2018 Nov; 9(11):202. PubMed ID: 30416197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    Zhang Y; Hu XY; Zhong S; Yang F; Zhou TY; Chen G; Wang YY; Luo JX
    World J Gastroenterol; 2014 Apr; 20(16):4745-52. PubMed ID: 24782628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B.
    Li J; Hu C; Chen Y; Zhang R; Fu S; Zhou M; Gao Z; Fu M; Yan T; Yang Y; Li J; Liu J; Chen T; Zhao Y; He Y
    BMC Infect Dis; 2021 Jun; 21(1):567. PubMed ID: 34126939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.
    Chen T; Yang Z; Choudhury AK; Al Mahtab M; Li J; Chen Y; Tan SS; Han T; Hu J; Hamid SS; Huei LG; Ghazinian H; Nan Y; Chawla YK; Yuen MF; Devarbhavi H; Shukla A; Abbas Z; Sahu M; Dokmeci AK; Lesmana LA; Lesmana CRA; Xin S; Duan Z; Guo W; Ma K; Zhang Z; Cheng Q; Jia J; Sharma BC; Sarin SK; Ning Q
    Hepatol Int; 2019 Nov; 13(6):695-705. PubMed ID: 31650510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis.
    Wang N; He S; Zheng Y; Wang L
    BMC Gastroenterol; 2023 Nov; 23(1):388. PubMed ID: 37957546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?
    Yan Y; Mai L; Zheng YB; Zhang SQ; Xu WX; Gao ZL; Ke WM
    World J Gastroenterol; 2012 Sep; 18(33):4604-9. PubMed ID: 22969236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
    Hyun JJ; Seo YS; Yoon E; Kim TH; Kim DJ; Kang HS; Jung ES; Kim JH; An H; Kim JH; Yim HJ; Yeon JE; Lee HS; Byun KS; Um SH; Kim CD; Ryu HS
    Liver Int; 2012 Apr; 32(4):656-64. PubMed ID: 22099071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure.
    Hossain SMS; Mahtab MA; Das DC; Noor-E-Alam SM; Mamun AA; Khan MSI; Akbar SMF; Rahman MZ; Rahman S
    J Family Med Prim Care; 2021 Jul; 10(7):2642-2645. PubMed ID: 34568149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    Garg H; Sarin SK; Kumar M; Garg V; Sharma BC; Kumar A
    Hepatology; 2011 Mar; 53(3):774-80. PubMed ID: 21294143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment.
    Zhang K; Lin S; Wang M; Huang J; Zhu Y
    Biomed Res Int; 2020; 2020():5728359. PubMed ID: 32596332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new simple scoring system to determine the timing and efficacy of entecavir therapy in hepatitis B-related acute-on-chronic liver failure].
    Li XY; Lei RX
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(4):291-294. PubMed ID: 30669716
    [No Abstract]   [Full Text] [Related]  

  • 15. Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study.
    Li YH; Xu Y; Wu HM; Yang J; Yang LH; Yue-Meng W
    Stem Cell Rev Rep; 2016 Dec; 12(6):645-653. PubMed ID: 27687792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Li X; Gao F; Liu H; Zhang H; Liu Y; Ye X; Geng M; Sun L; Wang R; Li Y; Jiang Y; Wang X; Zhou G; Yang Z; Li A; Zeng H; Wang X
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):1-9. PubMed ID: 27749778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
    Goyal SK; Dixit VK; Shukla SK; Ghosh J; Behera M; Tripathi M; Gupta N; Ranjan A; Jain AK
    Indian J Gastroenterol; 2015 Jul; 34(4):286-91. PubMed ID: 26243587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure.
    Lai J; Yan Y; Mai L; Zheng YB; Gan WQ; Ke WM
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):154-9. PubMed ID: 23558069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B.
    Jindal A; Vyas A; Sharma M; Kumar G; Sarin SK
    Saudi J Gastroenterol; 2019; 25(5):319-326. PubMed ID: 31044748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
    Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
    Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.